Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02752906 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

810

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Meningitis
Meningococcal Infections

Interventions

BIOLOGICAL: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
BIOLOGICAL: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company